Free Republic

A little-noticed provision of the omnibus spending bill could give the agency power to ban off-label use of approved therapies.. Secreted within the 2023 omnibus appropriations bill—4,155 pages, spending $1.7 trillion—is a 19-line section that could change the way medicine is practiced. Physicians routinely prescribe drugs and employ medical devices that are approved and labeled by the Food and Drug Administration for a particular use. Yet sometimes physicians discern other beneficial uses for these technologies, which they prescribe for their patients without specific official sanction. The new legislation amends the Food, Drug and Cosmetic Act, or FDCA, to give the...

ransomnote: A group of physicians, including Dr. Zelenko, Dr. McCullough, Dr. Risch along with others, created a one-stop website for treatment, access to doctors, education and also how to reduce Covid post-vaccination side effects.https://earlycovidcare.orgransomnote: Click the link to read the names of the expertise behind the websitehttps://earlycovidcare.org/our-expert/Here are their recommendations to reduce vaccination side-effects.DISCLAIMER: This information is for educational purposes only. It is not intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional. Any treatment you undertake should be discussed with your physician or other licensed medical professional.OTC Medicines & Nutraceuticals to...

White House chief of staff Mark Meadows said Sunday that the administration is “hopeful” it can announce new therapies to treat the coronavirus “in the coming days.” Meadows told ABC’s “This Week” that the White House has been “working around the clock,” with a focus on COVID-19 therapeutics, vaccines and mitigation therapies “The president has been very clear — whatever amount of money and whatever amount of time needs to be invested, we’re doing that,” the White House chief of staff said. "We're hopeful that with some of the breakthrough technology on therapeutics that we'll be able to announce some...

The first COVID-19 vaccine in China is expected to be ready for clinical trials by the end of April, according to Xu Nanping, China’s vice-minister of science and technology. Inovio Pharmaceuticals plans to begin clinical trials on a coronavirus vaccine in April this year. Health officials from WHO have noted that Gilead’s remdesivir has demonstrated efficacy in treating the coronavirus infection. Chloroquine approved for emergency use by US FDA The US Food and Drug Administration (FDA) approved limited emergency use for chloroquine and hydroxychloroquine as a treatment for COVID-19. The President of the United States, Donald Trump, had announced on...

A small, non-toxic molecule may soon be available as an inexpensive treatment for many forms of cancer, including lung, breast and brain tumours, say University of Alberta researchers. But there's a catch: the drug isn't patented, and pharmaceutical companies may not be interested in funding further research if the treatment won't make them a profit. In findings that "astounded" the researchers, the molecule known as DCA was shown to shrink lung, breast and brain tumours in both animal and human tissue experiments. "You typically get this eureka type of feeling. It's the most exciting thing a scientist can get," Dr....

Life expectancy is increasing in the developed world. But Cambridge University geneticist Aubrey de Grey believes it will soon extend dramatically to 1,000. Here, he explains why. Ageing is a physical phenomenon happening to our bodies, so at some point in the future, as medicine becomes more and more powerful, we will inevitably be able to address ageing just as effectively as we address many diseases today. I claim that we are close to that point because of the SENS (Strategies for Engineered Negligible Senescence) project to prevent and cure ageing. It is not just an idea: it's a very...